Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
YH-001 by Eucure (Beijing) Biopharma for Gastroesophageal (GE) Junction Carcinomas: Likelihood of Approval
YH-001 is under clinical development by Eucure (Beijing) Biopharma and currently in Phase I for Gastroesophageal (GE) Junction Carcinomas. According...
Data Insights
YH-001 by Eucure (Beijing) Biopharma for Solid Tumor: Likelihood of Approval
YH-001 is under clinical development by Eucure (Beijing) Biopharma and currently in Phase I for Solid Tumor. According to GlobalData,...